EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB)

被引：0

作者：

Schwarz, Kathleen B. ^{[1
]}

Bezerra, Jorge A. ^{[2
]}

Choe, Byung Ho ^{[3
,4
]}

Lin, Chuan-Hao ^{[5
]}

Abramov, Frida ^{[6
]}

Wang, Hongyuan ^{[6
]}

Liu, Yang ^{[6
]}

Flaherty, John F. ^{[6
]}

Pacurar, Daniela ^{[7
]}

Kim, Kyung Mo ^{[8
]}

Khaertynova, Ilsiyar ^{[9
]}

Shalimar ^{[10
]}

Wu, Jia-Feng ^{[11
]}

Tandon, Manish ^{[12
]}

Rosenthal, Philip ^{[13
]}

Morozov, Viacheslav ^{[14
]}

Sokal, Etienne M. ^{[15
]}

Chang, Mei Hwei ^{[16
,17
]}

机构：

[1] Univ Calif San Diego, Rady Childrens Hosp San Diego, San Diego, CA 92103 USA

[2] Univ Texas Southwestern Med Ctr, Dallas, TX USA

[3] Kyungpook Natl Univ, Sch Med, Daegu, South Korea

[4] Kyungpook Natl Univ Childrens Hosp, Daegu, South Korea

[5] Childrens Hosp Los Angeles, Los Angeles, CA USA

[6] Gilead Sci Inc, Foster City, CA USA

[7] Carol Davila Univ Med & Pharm, Bucharest, Romania

[8] Univ Ulsan, Asan Med Ctr, Childrens Hosp, Seoul, South Korea

[9] Kazan State Med Univ, Kazan, Russia

[10] All India Inst Med Sci, Delhi, India

[11] Natl Taiwan Univ Hosp, Taipei, Taiwan

[12] MV Hosp & Res Ctr, Lucknow, Uttar Pradesh, India

[13] Univ Calif San Francisco, San Francisco, CA 94143 USA

[14] Hepatolog Med Co, Samara, Russia

[15] Clin Univ St Luc, Brussels, Belgium

[16] Natl Taiwan Univ, Taipei, Taiwan

[17] Children Hosp, Taipei, Taiwan

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1414C

引用

页码：S515 / S517

页数：3

共 50 条

[31] EFFICACY AND SAFETY RESULTS 48 WEEKS AFTER SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) VS CONTINUED TDF TREATMENT IN VIROLOGICALLY-SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Lampertico, Pietro
Buti, Maria
Fung, Scott
Ahn, Sang Hoon
Chuang, Wan-Long
Tak, Won Young
Ramji, Alnoor
Chen, Chi-Yi
Tam, Edward
Bae, Ho
Ma, Xiaoli
Flaherty, John F.
Gaggar, Anuj
Lau, Audrey H.
Feierbach, Becket
Wu, George
Suri, Vithika
Subramanian, Mani
Trinh, Huy N.
Yoon, Seung-Kew
Agarwal, Kosh
Lim, Young-Suk
Chan, Henry L.
GASTROENTEROLOGY, 2019, 156 (06) : S1195 - S1195
[32] Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive chronic hepatitis B
Lim, Jihye
Choi, Won-Mook
Shim, Ju Hyun
Lee, Danbi
Kim, Kang Mo
Lim, Young-Suk
Lee, Han Chu
Choi, Jonggi
LIVER INTERNATIONAL, 2022, 42 (07) : 1517 - 1527
[33] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE AFTER SWITCHING FROM ENTECAVIR IN PATIENTS WITH CHRONIC HEPATITIS B
Hann, Hie-Won L.
Park, Grace
Bin Park, Kyong
Juon, Hee-Soon
HEPATOLOGY, 2021, 74 : 480A - 480A
[34] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN PATIENTS WITH DECOMPENSATED HEPATITIS B CIRRHOSIS
Deng, You
Cui, Weili
Yue, Jin
Li, Jinlong
Zhang, Shuqian
Wang, Qi
Zhao, Hong
Chen, Wenya
Li, Jiashuo
Li, Mengqi
Lai, Xiaohuan
Guo, Xiaoqing
Qiao, Bing
Xie, Wen
HEPATOLOGY, 2024, 80 : S1696 - S1697
[35] From Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF): Perspectives in Pediatric Patients with Chronic Hepatitis B
Rodrigo, Minna
Hartley, Christopher
Wasuwanich, Paul
Van, Trung
Karnsakul, Wikrom
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (12) : 1099 - 1106
[36] Safety and efficacy in lamivudine (LAM) experienced chronic hepatitis B (CHB) patients treated for 2 years with tenofovir disoproxil fumarate (TDF)
Roberts, S. K.
Gane, E. J.
Weilert, F.
Sievert, W.
George, J.
Strasser, S. I.
Kronborg, I.
Heathcote, E. J.
Marcellin, P.
Sorbel, J.
Rousseau, F.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A299 - A299
[37] Efficacy and safety of tenofovir alafenamide in patients with chronic hepatitis B exhibiting suboptimal response to entecavir
Yuan, Gui-Cai
Chen, Ai-Zhen
Wang, Wei-Xin
Yi, Xu-Lan
Tu, Long
Peng, Fang
Qiu, Zhi-Hong
WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (34) : 8139 - 8146
[38] COMPARATIVE SAFETY OF TENOFOVIR DISOPROXIL FUMARATE AND TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS
Yu, N. Y.
Chang, K. C.
VALUE IN HEALTH, 2020, 23 : S532 - S532
[39] Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive patients with chronic hepatitis B
Lim, Jihye
Choi, Won-Mook
Shim, Ju Hyun
Lee, Danbi
Kim, Kang Mo
Lim, Young-Suk
Lee, Han Chu
Choi, Jonggi
JOURNAL OF HEPATOLOGY, 2022, 77 : S842 - S842
[40] Hepatic safety of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF)
Johnson, M.
Taylor, S.
Wei, X.
Collins, S.
Martin, H.
HIV MEDICINE, 2019, 20 : 40 - 40

← 1 2 3 4 5 →